Safety profile of methotrexate in inflammatory bowel disease.

about

The safety of non-biological treatments in Ulcerative Colitis.The current therapeutic options for Crohn's disease: from medical therapy to intestinal transplantation.

P2860

Q38728164-CA626AD2-C572-4DFB-9E03-AD3629C5F341 Q47798734-D00D7E5F-7E6B-4C4A-B0FD-27C3E2B8F237

P2860

Safety profile of methotrexate in inflammatory bowel disease.

Item

http://www.wikidata.org/entity/Q38909929

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Safety profile of methotrexate in inflammatory bowel disease.

@en

type

Item

label

Safety profile of methotrexate in inflammatory bowel disease.

@en

prefLabel

Safety profile of methotrexate in inflammatory bowel disease.

@en

P1476

Safety profile of methotrexate in inflammatory bowel disease.

@en

P2093

Natalia Manetti

http://www.w3.org/2001/XMLSchema#string

Sarah Lunardi

http://www.w3.org/2001/XMLSchema#string

Simona Deiana

http://www.w3.org/2001/XMLSchema#string

Vito Annese

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease.

Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients.

Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials.

Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease.

Teratogen update: methotrexate.

Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother.

Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.

Methotrexate: first-line or second-line immunomodulator?

P304

1427-1437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14740338.2016.1218468

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

T Gabbani

P577

2016-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27462711

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

Safety profile of methotrexate in inflammatory bowel disease.

about

P2860

P2860

Safety profile of methotrexate in inflammatory bowel disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921